If you are eligible for the Tafinlar patient assistance program, the cost of your medication will be free. We only charge $49 a month, per medication, to cover our service fees. You could receive your Tafinlar prescription for just $49 a month, regardless of the retail price of your medication.
Full Answer
What is the co-pay for Tafinlar?
Patients may be eligible for immediate co-pay savings on their next prescription: Eligible patients with private insurance may pay $0 per month ($0 per month for a 30-day supply of TAFINLAR ® [dabrafenib] capsules and $0 for a 30-day supply of MEKINIST ® [trametinib] tablets).
What is Tafinlar used to treat?
TAFINLAR, in combination with MEKINIST, is indicated for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, and involvement of lymph node (s), following complete resection. Limitation of Use: TAFINLAR is not indicated for the treatment of patients with wild-type BRAF melanoma.
How do I get Tafinlar and Mekinist?
With the Free Trial and Access Program, you can receive a free supply of TAFINLAR and MEKINIST for a US Food and Drug Administration–approved indication. The supply can be shipped directly to your home or another convenient location so you can start treatment immediately. Program rules may vary by product.
How do I get an offer from Tafinlar?
Tafinlar offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
What is the cost of TAFINLAR?
Learn more about this drug here . This is a brand name drug and a generic may be available. The average cost for 120 Capsule(s), 75mg each, is $14,986.80. You can buy Tafinlar at the discounted price of $12,299.26 by using the WebMDRx coupon, a savings of 18%.
What is TAFINLAR used for?
TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “BRAF V600E” gene.
What is the income requirements for Novartis patient assistance?
To be eligible for NPAF assistance, you must:Household SizeAnnual Household Income Threshold2 People< USD 100 0003 People< USD 125 0004 People< USD 150 000> 5 PeopleAdd USD 25 000 for each additional person1 more row
Can you take TAFINLAR without MEKINIST?
It is important to take TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets exactly as your health care provider tells you.
What are the side effects of Tafinlar?
Common side effects of TAFINLAR and MEKINIST in people with NSCLC include:Fever.Tiredness.Nausea.Vomiting.Diarrhea (call your health care provider if you get severe diarrhea)Dry skin.Decreased appetite.Rash.More items...
Is Tafinlar targeted therapy?
Tafinlar is a targeted therapy that targets the mutated BRAF proteins (kinase) within the cancer cell. The BRAF gene plays an important role in both normal and cancer cells.
Is it hard to get into Novartis?
In a more up-to-date source, Glassdoor indicates that 67 percent of people who went through the interview process at Novartis had a positive experience and reported it as having average difficulty.
Which customers are eligible to access pharmaceutical benefits?
Who is eligible for the PBS? The Scheme is available to all Australian residents who hold a current Medicare card. Overseas visitors from countries with which Australia has a Reciprocal Health Care Agreement (RHCA) are also eligible to access the Scheme.
Is prescription hope based on income?
With respect to Prescription Hope's simple eligibility guidelines, individuals need to earn $32,000 per year or less, or have a combined household income of $50,000 per year or less.
Is it best to take Tafinlar before or after meal?
Since TAFINLAR + MEKINIST is an oral melanoma treatment, you'll take it by mouth—at least 1 hour before or at least 2 hours after eating. Do not open, crush, or break TAFINLAR capsules.
What are the side effects of Mekinist?
Dizziness, diarrhea, nausea/vomiting, stomach pain, dry/itchy skin, acne, and dry mouth may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Can dabrafenib cure melanoma?
Through clinical trials, cancer researchers have found that combining dabrafenib and trametinib can treat advanced melanoma more effectively than either medication on its own. The combination also produces less serious side effects than the single drugs used alone.
Is it best to take Tafinlar before or after meal?
Since TAFINLAR + MEKINIST is an oral melanoma treatment, you'll take it by mouth—at least 1 hour before or at least 2 hours after eating. Do not open, crush, or break TAFINLAR capsules.
Can dabrafenib cure melanoma?
Through clinical trials, cancer researchers have found that combining dabrafenib and trametinib can treat advanced melanoma more effectively than either medication on its own. The combination also produces less serious side effects than the single drugs used alone.
How long does Tafinlar and Mekinist work?
The median (or midpoint) duration of response for patients who have never been treated was 15.2 months. That means that half of the patients who responded to treatment continued to respond longer than 15.2 months and half responded for less than 15.2 months.
What conditions is Aminoglutethimide used to treat?
Aminoglutethimide is used to treat some kinds of tumors that affect the adrenal cortex. Also, it is sometimes used when the adrenal cortex is overactive without being cancerous.
What is a tafinar?
TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “ BRAF V ... See More
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine (s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.
Does Novartis offer oncology?
Novartis Oncology is committed to helping you get the Novartis medicine (s) you need. Access to medicine (s) can sometimes be difficult or confusing. PANO offers resources and support designed specifically to help make that process easier.* PANO can offer the following services:
What is Tafinlar used for?
Tafinlar (dabrafenib) is a member of the multikinase inhibitors drug class and is commonly used for Melanoma - Metastatic, Non-Small Cell Lung Cancer, and Thyroid Cancer.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Does Clozarila have a pharmacy card?
For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the patient, unless otherwise noted. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Is Tafinlar a generic?
Tafinlar is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Tafinlar availability . This Tafinlar price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
What is a tafinar?
TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “ BRAF V600E” gene.
How old do you have to be to take tafenar?
You must be 18 years of age or older to participate in this program.
What is a Novartis patient navigator?
The Novartis Patient Navigator Program is staffed by a team of specialists who are available to support you during your treatment journey. Once enrolled in the program, you will receive a series of phone calls from a specially trained navigator who will help you understand the results of your benefits investigation, educate you about financial assistance options, and help you get started on your Novartis medicine (s).
Can tafinil cause blood clots?
Blood clots. TAFINLAR and MEKINIST in combination can cause blood clots in your arms or legs, which can travel to your lungs and lead to death. Get medical help right away if you have the following symptoms:
Can tafinar cause bleeding?
Bleeding problems. TAFINLAR and MEKINIST in combination can cause serious bleeding problems, especially in your brain or stomach, that can lead to death. Call your health care provider and get medical help right away if you have any signs of bleeding, including:
Can tafinar cause breathing problems?
Lung or breathing problems. TAFINLAR and MEKINIST, in combination, can cause lung or breathing problems. Tell your health care provider if you have any new or worsening symptoms of lung or breathing problems, including:
Can tafinar cause high blood sugar?
Increased blood sugar (hyperglycemia). Some people may develop high blood sugar or worsening diabetes during treatment with TAFINLAR and MEKINIST in combination. If you are diabetic, your health care provider should check your blood sugar levels closely during treatment with TAFINLAR and MEKINIST. Your diabetes medicine may need to be changed. Tell your health care provider if you have any of the following symptoms of severe high blood sugar:
What is tafinar used for?
Indications TAFINLAR, in combination with MEKINIST, is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.
What is a tafenar capsule?
TAFINLAR ® (dabrafenib) capsules, in combination with MEKINIST ® (trametinib) tablets, is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.
How to assess LVEF?
Assess LVEF by echocardiogram or multigated acquisition (MUGA) scan before initiation of the combination, 1 month after initiation, and then at 2- to 3-month intervals while on treatment. Withhold TAFINLAR for symptomatic cardiomyopathy or asymptomatic left ventricular dysfunction of >20% from baseline that is below institutional LLN. Resume TAFINLAR at the same dose level upon recovery of cardiac function to at least the institutional LLN for LVEF and absolute decrease ≤10% compared to baseline. For an asymptomatic absolute decrease in LVEF of 10% or greater from baseline that is below the LLN, withhold MEKINIST for up to 4 weeks. If improved to normal LVEF value, resume at a lower dose. If no improvement to normal LVEF value within 4 weeks, permanently discontinue MEKINIST. For symptomatic cardiomyopathy or an absolute decrease in LVEF of >20% from baseline that is below LLN, permanently discontinue MEKINIST.
Does tafinar cause malignancies?
Based on its mechanism of action, TAFINLAR may promote the growth and development of malignancies with activation of monomeric G protein (RAS) through mutation or other mechanisms. Across clinical trials of TAFINLAR monotherapy and the combination, noncutaneous malignancies occurred in 1% of patients.
Is tafinar a melanoma drug?
TAFINLAR, in combination with MEKINIST, is indicated for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, and involvement of lymph node (s), following complete resection.
How to contact Novartis oncology?
Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
Is tafinar safe for melanoma?
Limitation of Use: TAFINLAR is not indicated for the treatment of patients with wild-type BRAF melanoma.
Patient Website
Our patient website is a helpful resource for patients taking TAFINLAR ® (dabrafenib) capsules + MEKINIST ® (trametinib) tablets, providing the Medication Guide, information on co-pay assistance, and downloadable support materials. Visit the site at us.tafinlarmekinist.com.
NEXT: Video Library
TAFINLAR ® (dabrafenib) capsules, in combination with MEKINIST ® (trametinib) tablets, is indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.
